Willkommen bei Valicare!
-
Unsere Experten bieten GMP-Beratung, Konzeptionierung und Unterstützung vor Ort!
Rufen Sie an: +49 69 153 293 701
Mehr erfahren -
Unsere Experten bieten GMP-Beratung, Konzeptionierung und Unterstützung vor Ort!
Rufen Sie an: +49 69 153 293 701
Mehr erfahren
Events
-
19 Nov 202020 Nov 2020Frankfurt am Main / Deutschland 2nd APV Interactive Workshop on ATMP Am 19. und 20. November dieses Jahres wird der zweite APV Experten-Workshop diesmal zum Thema “Bridging standard pharma concepts and ATMP” stattfinden.
-
13 Apr 202114 Apr 2021Stuttgart / Deutschland Deutsche Biotechnologie-Tage Forum für den Erfahrungsaustausch zwischen allen Akteuren der deutschen Biotechnologieszene
-
11 Mai 202114 Mai 2021Wien / Österreich PBP World Meeting 12. Welttreffen über Pharmazeutik, Biopharmazie und pharmazeutische Technologie
Nachrichten aus aller Welt
Unser internationaler Pressespiegel zeigt eine Auswahl an Nachrichten und neusten Artikel zu den Themen Arzneimittel neuartiger Therapien (ATMP), Chimäre Antigenrezeptor(CAR)-T-Zell-Therapie, Tumor infiltrierende Lymphozyten (TIL) und biotechnologisch bearbeitete Gewebeprodukte (TEP).
Valicare extends GxP expertise
26.10.2020 | Process & Control Today26/10/2020 Syntegon Technology GmbH (formerlyBosch Packaging) New consulting services for the transition from development to clinical ...
CAR-T in solid tumors: Blazing a new trail through the brambles
26.10.2020 | Science DirectAbstract Chimeric antigen receptor-modified T cell therapy (CAR-T) is known to exhibit distinctive precision, extensiveness, and ...
Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis
24.10.2020 | DocWire NewsThis article was originally published here Cell Prolif. 2020 Oct 24:e12939. doi: 10.1111/cpr.12939. Online ahead of print. ABSTRACT ...
Collagen scaffold for mesencyhmal stem cell from stromal vascular fraction (biocompatibility and attachment study): Experimental paper
24.10.2020 | Science DirectHighlights • Biocompatibility and attachment of collagen scaffold. • Measuring the level of availability of mesenchymal stem cell (MSC) ...
The European Medicines Agency recommends 10 medicines for approval in October meeting
22.10.2020 | PharmaFileThe EMA has recommended marketing authorisation for ten medicines and has also suggested ten label extensions. The agency’s Committee for ...
23. Juni 2020 Frühes TNBC: Wirksamkeit des neoadjuvanten Einsatzes von Atezolizumab belegt
22.10.2020 | Journal Onkologie
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial
21.10.2020 | British Medical JournalAndy Roemhild, scientist1 2, Natalie Maureen Otto, nephrologist1 2 3, Guido Moll, scientist1, Mohamed Abou-El-Enein, physician1 2, ...
How Kite is Building its CAR-T Franchise Despite COVID-19 Restrictions
20.10.2020 | Bio SpaceKite, a Gilead company, is building a franchise, not just a brand, on the promise of its CAR-T cell therapies. Despite COVID, it has opened...
New Approach for CAR-T Cell “Purification” May Reduce Side Effects and Toxicity
20.10.2020 | DocWire NewsResearchers from the biotherapeutics company Carina Biotech and the University of South Australia have developed a novel, microfluidic ...
Mesenchymal stromal cells for osteonecrosis
20.10.2020 | Journal of Translational MedicineAbstract Osteonecrosis (ON) is an acquired debilitating skeletal disorder, which is caused by a multitude of traumatic and non-traumatic ...
Tecartus Recommended for EU Approval as CAR T-cell Therapy for Mantle Cell Lymphoma
19.10.2020 | Immuno-oncology NewsClick here to subscribe to the Immuno-Oncology News Newsletter!
Ten new medicines backed for EU approval
19.10.2020 | PharmaTimesThe European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended ten new medicines for approval ...
Trending News on Targeted Oncology, Week of October 16, 2020
16.10.2020 | Targeted OncologyThis week, the FDA granted approval to pembrolizumab (Keytruda) as treatment of patients with relapsed/refractory classical Hodgkin ...
Zwei ATMP zur Zulassung empfohlen
16.10.2020 | Pharmazeutische Zeitung Online
Positive CHMP opinion for gene therapy Libmeldy™ for the treatment of Early-Onset Metachro...
16.10.2020 | BioPharmAnalysesThe Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion ...
Valicare – kompetent, zuverlässig & effizient
Sie haben wenig Zeit und möchten trotzdem wissen, welche Dienstleistungen die Valicare GmbH anbietet?